Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829809) titled 'Serum Adropin as an Indicator of Endothelial Dysfunction and Disease Severity in Obstructive Sleep Apnea in Obese Patients' on Sept. 15.
Study Type: Observational
Primary Sponsor: Aswan University
Condition:
Adropin In Patients of OSA
Intervention:
Diagnostic Test: Adropin
Recruitment Status: Not recruiting
Date of First Enrollment: September 15, 2026
Target Sample Size: 80
To know more, visit https://clinicaltrials.gov/study/NCT07829809
Published by HT Digital Content Services with permission from Health Daily Digest....